Oscillococcinum – ASA complaint

Posted 11 December 2012


 A complaint was laid with the ASA against certain claims made for this product. The company assured the ASA that they had removed the claims and that “[I]t confirmed that the claims objected to ‘will not be used in future’.” 

Oscillococcinum / HA Steinman / 21248
Ruling of the : ASA Directorate
In the matter between:
Dr Harris Steinman Complainant(s)/Appellant(s)
Glenmark Pharhaceuticals South Africa (Pty) Ltd Respondent

04 Dec 2012
Dr Steinman lodged a consumer complaint against a Glenmark Pharmaceuticals’ Internet advertisement promoting Oscillococcinum. The advertisement was published at, and claims, inter alia, that:

“… Oscillococcinum acts on the upper respiratory and respiratory system. This medicine is designed to correct imbalances within an unhealthy body and to stimulate the body’s reactive defense [sic] mechanism to overcome the disease, illness or condition”.

Under the “Product description” section, it notes the “Indications:” as “Prevention and Read the rest

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>




This site uses Akismet to reduce spam. Learn how your comment data is processed.